Allergy Therapeutics reports rise in first half profits and revenue
Allergy Therapeutics reported an 11 per cent rise in gross profit to 20.7m pounds in the first half as costs were reduced. The cost of goods fell to £6.4m in the last six months of 2013, compared to £7m, following a number of cost cutting measures. Gross revenue, excluding the German rebate and
Read more